Provided by Tiger Fintech (Singapore) Pte. Ltd.

BridgeBio Pharma, Inc.

45.90
-0.6100-1.31%
Post-market: 45.41-0.4904-1.07%19:16 EDT
Volume:2.36M
Turnover:109.19M
Market Cap:8.72B
PE:-12.98
High:47.40
Open:47.34
Low:45.81
Close:46.51
Loading ...
Dec 07, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Dec 06, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Dec 06, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 18, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 18, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Oct 26, 2021

Major Issues Report

8-K - Current report
Aug 23, 2021

Major Issues Report

8-K - Current report
Aug 13, 2021

Major Issues Report

8-K - Current report
Aug 05, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 22, 2021

Major Issues Report

8-K - Current report
Jun 01, 2021

Major Issues Report

8-K - Current report
May 14, 2021

Major Issues Report

8-K - Current report
May 11, 2021

Major Issues Report

8-K - Current report
May 06, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 15, 2021

Major Issues Report

8-K - Current report
Mar 31, 2021

Major Issues Report

8-K - Current report
Feb 26, 2021

Major Issues Report

8-K - Current report
Feb 25, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 17, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Feb 17, 2021

Major Issues Report

8-K - Current report